Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients
融合驱动型B细胞急性淋巴细胞白血病（B-ALL）患者在造血干细胞移植（HSCT）前后应用酪氨酸激酶抑制剂（TKI）治疗：5例儿童、青少年和青年患者的病例系列研究
期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1901
Shumock, Savannah S; Temple, William C; Marinoff, Amanda; Aaronson, Kathryn; Southworth, Erica; Xirenayi, Simayijiang; Lee, Alex G; Leung, Stanley G; Sweet-Cordero, E Alejandro; Hermiston, Michelle; Higham, Christine; Stieglitz, Elliot
B细胞
发育与干细胞
信号转导
白血病
干细胞
细胞生物学
免疫/内分泌
